Free Trial

Catalyst Pharmaceuticals (CPRX) SEC Filings & 10K Form

Catalyst Pharmaceuticals logo
$21.27 -0.19 (-0.89%)
(As of 12/20/2024 05:45 PM ET)

Recent Catalyst Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/17/2024
4:24 PM
Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Thompson Tamar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
11:55 AM
Catalyst Pharmaceuticals (Subject)
Miller Steve (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
7:08 PM
Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
7:09 PM
Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
7:09 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
1:42 PM
Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
8:42 AM
Catalyst Pharmaceuticals (Subject)
Harper Molly (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
11:37 AM
Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Thompson Tamar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM
Catalyst Pharmaceuticals (Issuer)
Kalb Michael Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM
Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM
Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM
Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:01 PM
Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
4:11 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
1:57 PM
Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:55 AM
Catalyst Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G/A
11/13/2024
4:44 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
9:52 AM
Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
4:10 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:08 PM
Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
10/18/2024
2:31 PM
BlackRock, Inc. (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G/A
10/17/2024
11:14 AM
Catalyst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
09/26/2024
7:42 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
1:21 PM
Catalyst Pharmaceuticals (Subject)
Tierney David S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
3:42 PM
Catalyst Pharmaceuticals (Subject)
Miller Steve (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
1:53 PM
Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
10:24 AM
Catalyst Pharmaceuticals (Subject)
Del Carmen Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
3:32 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:30 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
10:17 AM
Catalyst Pharmaceuticals (Subject)
Del Carmen Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
2:22 PM
Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2024
9:41 AM
Catalyst Pharmaceuticals (Subject)
Daly Richard J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
11:22 AM
Catalyst Pharmaceuticals (Subject)
Harper Molly (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
3:50 PM
Catalyst Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/31/2024
3:43 PM
Catalyst Pharmaceuticals (Filer)
Form POS EX
05/31/2024
3:46 PM
Catalyst Pharmaceuticals (Filer)
Form POS EX
05/31/2024
3:47 PM
Catalyst Pharmaceuticals (Filer)
Form POS EX
05/30/2024
3:43 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
4:28 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
4:15 PM
Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:23 PM
Catalyst Pharmaceuticals (Filer)
Form DEF 14A
04/10/2024
3:25 PM
Catalyst Pharmaceuticals (Filer)
Form ARS
04/08/2024
1:03 PM
Catalyst Pharmaceuticals (Subject)
Tierney David S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/28/2024
3:45 PM
Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
2:01 PM
Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2024
4:01 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
4:16 PM
Catalyst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2024
4:31 PM
Catalyst Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G/A
02/06/2024
4:00 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:01 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
9:09 AM
Catalyst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/09/2024
4:15 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
7:10 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
4:23 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
4:15 PM
Catalyst Pharmaceuticals (Filer)
Form 424B5
01/03/2024
4:18 PM
Catalyst Pharmaceuticals (Issuer)
Kalb Michael Wayne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2024
4:18 PM
Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:18 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:19 PM
Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:19 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:00 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:00 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:00 PM
Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:00 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Why I'm telling friends to avoid gold stocks (Ad)

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.
12/29/2023
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:00 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:00 PM
Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CPRX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners